Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.
------------------------------------------------------------
April 18, 2003
U.S. IMMUNIZATION NEWS
"DynPort Vaccine"
Washington Post (www.washingtonpost.com) (04/18/03) P. E5
DynPort Vaccine, a joint venture between Computer Sciences Corp. and Porton International, conducted a study involving 150 patients and a diluted dose of the company's smallpox vaccine, called CCSV. The vaccine, even when diluted up to 50 times, produced positive results in all but one of the 100 people who had not previously received a smallpox vaccination. CCSV is also associated with fewer side effects when compared to patients receiving the traditional smallpox vaccine, Dryvax.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.